Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Cancer Research|September 23, 2011
Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognitionEmilie Mamessier, Aude Sylvain, François Bertucci, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blastsJulie Gertner-Dardenne, Remy Castellano, Emilie Mamessier, et al.Oncotarget|February 12, 2015
Prognostic and predictive value of PDL1 expression in breast cancerRenaud Sabatier, Pascal Finetti, Emilie Mamessier, et al.Cancers|March 10, 2022
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune ResponseAlexandre de Nonneville, Pascal Finetti, Maelle Picard, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsetsEmilie Mamessier, Lydie C Pradel, Marie-Laure Thibult, et al.Oncoimmunology|April 14, 2017
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomasFrançois Bertucci, Pascal Finetti, Delphine Perrot, et al.Journal of Translational Medicine|October 11, 2022
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune responseLaurys Boudin, A de Nonneville, Pascal Finetti, et al.British Journal of Cancer|October 25, 2018
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancerFrançois Bertucci, Pascal Finetti, Ines Simeone, et al.BMC Medicine|September 21, 2017
A 25-gene classifier predicts overall survival in resectable pancreatic cancerDavid J Birnbaum, Pascal Finetti, Alexia Lopresti, et al.Cancers|January 21, 2023
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular CarcinomaDavid Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, et al.Pageof 9